Skip to main content
. 2019 Aug 19;71(2):422–430. doi: 10.1002/hep.30830

Table 1.

Patient Demographics and Baseline Characteristics

Children 3 to <6 Years Old (N = 34)
Median (range) age, years 5 (3, 5)
Female, n (%) 24 (71)
Race, n (%)
White 27 (79)
Black or African American 1 (3)
Asian 2 (6)
Other 4 (12)
Ethnicity, n (%)
Hispanic or Latino 6 (18)
Region, n (%)
United States (US) 29 (85)
Non‐US 5 (15)
Median (range) weight, kg 19 (11, 34)
Weight <17 kg, n (%) 24 (71)
Median weight for age percentile (IQR) 64.7 (26.8, 78.9)
Median (range) height, cm 107 (89, 120)
Median (range) BMI, kg/m2 16 (13, 25)
Median BMI for age percentile (IQR) 71.8 (47.0, 95.8)
HCV genotype, n (%)
1a 28 (82)
1b 5 (15)
4 1 (3)
Median (range) HCV RNA, log10 IU/mL 6.0 (4.8, 7.3)
HCV RNA ≥800,000 IU/mL, n (%) 19 (56)
HCV‐treatment naive, n (%) 34 (100)
Cirrhosis, n (%)
No 14 (41)
Yes 0
Unknown 20 (59)
Median (range) ALT, U/L 52 (25, 130)
Median (range) eGFR,* (mL/min/1.73 m2) 171 (99, 220)
Mode of HCV infection, n (%)
Perinatal transmission 34 (100)
*

Estimated using Schwartz Formula.

Abbreviations: ALT, alanine aminotransferase; IQR, interquartile range.